BIOMAT Database Logo BIOMAT Database Logo

[Optimization of the technology and a biopharmaceutic study of mefenamic acid suppositories]. 1978

V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort

UI MeSH Term Description Entries
D008528 Mefenamic Acid A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase. Apo-Mefenamic,Contraflam,Coslan,Dysman,Mefac,Mefacit,Mefenaminic Acid,Mefic,Nu-Mefenamic,PMS-Mefenamic Acid,Parkemed,Pinalgesic,Ponalar,Ponalgic,Ponmel,Ponstan,Ponstan Forte,Ponstel,Ponsyl,Pontal,Acid, Mefenamic,Apo Mefenamic,Nu Mefenamic,PMS Mefenamic Acid
D010592 Pharmaceutic Aids Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include SOLVENTS, diluting agents, and suspending agents, and emulsifying agents. Also, ANTIOXIDANTS; PRESERVATIVES, PHARMACEUTICAL; COLORING AGENTS; FLAVORING AGENTS; VEHICLES; EXCIPIENTS; OINTMENT BASES. Aids, Pharmaceutic,Aids, Pharmaceutical,Pharmaceutical Aids
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal
D013501 Surface-Active Agents Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. Surface Active Agent,Surface-Active Agent,Surfactant,Surfactants,Tenside,Amphiphilic Agents,Surface Active Agents,Tensides,Active Agent, Surface,Active Agents, Surface,Agent, Surface Active,Agent, Surface-Active,Agents, Amphiphilic,Agents, Surface Active,Agents, Surface-Active
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D013678 Technology, Pharmaceutical The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients. Technology, Pharmacy,Pharmaceutic Technology,Pharmaceutical Technology,Pharmacy Technology,Technology, Pharmaceutic

Related Publications

V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Biopharmaceutic and pharmacokinetic studies on piroxicam suppositories].
November 1986, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Optimization of the technology and a study of rectal drug forms. II. The technology and biopharmaceutical study of molded suppositories of sodium mephenaminate].
January 1978, Farmatsevtychnyi zhurnal,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Biopharmaceutic and technological investigation of vagina suppositories containing brilliant green].
May 2008, Georgian medical news,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Biopharmaceutical evaluation of the rectal application of mefenamic acid. I. Study of the suppositories prepared on hydrophilic bases].
January 1983, Acta poloniae pharmaceutica,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Anal suppositories containing antiphlogistic and analgesic substances. III. Stability of anal suppositories containing mefenamic acid prepared on selected hydrophobic bases].
January 1985, Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Optimization of technology and a study of rectal drug forms. II. Production and biopharmaceutical study of pressed suppositories with butadione].
January 1978, Farmatsevtychnyi zhurnal,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid.
January 2017, PloS one,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Biopharmaceutical evaluation of the rectal administration of mefenamic acid. II. Analysis of suppositories prepared on lipophilic bases].
January 1984, Acta poloniae pharmaceutica,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Application of a factorial experimental project for optimization of manufacturing technology for theophylline suppositories].
September 1988, Acta pharmaceutica Hungarica,
V A Golovkin, and E P Lukash, and A G Fadeicheva, and T A Groshovyĭ, and N A Mokhort
[Technology optimization and a study of rectal drug forms. I. The use of experimental design in the technology of pediatric molded suppositories made of sodium mefenaminate].
January 1976, Farmatsevtychnyi zhurnal,
Copied contents to your clipboard!